Alessandra Rasmussen has been named business unit leader for proteomics and array systems for PerkinElmer, putting the two business units of the Wellesley, Mass.-based company under the leadership of one person, the company told BioArray News last week. “The infrastructure and teams and products for microarrays and proteomics remain unchanged,” said Dan Sutherby, PerkinElmer vice president for investor relations. “We have a presence in microarrays, as it pertains to oligos and cDNA, and we have a large effort in proteomics, so it made sense to us to appoint a single leader to run and manage the product offerings. But there will be no change in the people in those businesses, the strategies, or the products.”
Thomas Yager joins Toronto’s ChondroGene as director, product development and quality assurance. Yager previously was director of technology transfer for Visible Genetics, also of Toronto. Yager holds a PhD in biochemistry and biophysics from Oregon State University and completed postgrad work at the University of Oregon, the Weizmann Institute in Israel and Kings College in London.
Thomas McNaughton joins Zyomyx of Hayward, Calif., as vice president of intellectual property, the company said last week. Previously, he was vice president, legal affairs, for Aclara Biosciences. McNaughton holds a JD from the University of Michigan, and a BS in science and engineering from the US Military Academy.
Additionally, John Lewis was named vice president, sales and marketing, for Zyomyx, replacing Hirday Bhathal, who resigned as vice president, corporate development. Lewis was vice president of customer development and world-wide technical support for BD Biosciences Clontech. He holds a BS in zoology from the University of Florida.